Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immuno-oncology
Manufacturing
Merck's BCG monopoly could end
ImmunityBio's newly approved Anktiva must be used alongside BCG, which is solely supplied by the company's competitor in bladder cancer, Merck & Co.
Angus Liu
May 3, 2024 10:50am
Soon-Shiong's ImmunityBio bags FDA nod for bladder cancer drug
Apr 22, 2024 10:40pm
Leqembi, Takeda, Fujifilm Diosynth—Fierce Pharma Asia
Apr 19, 2024 9:20am
AACR: Detailed data spark hope for Merck combo in NSCLC
Apr 9, 2024 1:16pm
AstraZeneca’s Imfinzi tackles another type of lung cancer
Apr 5, 2024 10:22am
BMS shoots for 1L liver cancer again with Opdivo, Yervoy combo
Mar 20, 2024 10:18am